To Evaluate the Beneficial Effect of Probiotics on NAFLD Patients and the Role of Gut Microbiota Modulation
Clinical trial NCT05402449 · COMPLETED
Trial details
- NCT number
- NCT05402449
- Sponsor
- GenMont Biotech Incorporation
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-14
- Primary completion
- 2024-05-31
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.